Purpose: To compare of changes in glomerular filtration rate (GFR) in patients who underwent radical cystectomy (RC) and multimodal treatment (MMT).
Materials and Methods: We identified 472 consecutive patients who underwent RC or treated with MMT for muscle invasive bladder cancer (MIBC) at our institution, between January 1995 and December 2010. After excluding the patients who died within 5 years or without 5 years of follow-up, 175 and 59 patients who were treated with RC and MMT, respectively were included to the study. GFR was measured before treatment and every 6 months after treatment till the end of 60th month.
Results: The mean age and mean baseline GFR were 66.5±5.7 years and 85.1±18.2 mL/min/1.73m2, respectively for all patients. We detected statistically significant higher decrease rates for GFRs in MMT group compared to RC group at every follow up period till 42nd month. Renal function decreasing was found to be more prominent during first year of follow-up (79.1 to 65.9 mL/min/1.73m2) in MMT group. However, GFR decreased more regularly in RC group (~4 mL/min/1.73m2 per year). MMT, lower baseline GFR, Diabetes Mellitus, hypertension, and ureteroenteric anastomotic stricture development were associated with low GFR under 60 and 45 mL/min at the end of five years.
Conclusion: Decreased renal function is noted in many MIBC patients after RC or MMT in the long-term follow-up. Renal function deterioration is more prominent within the first year after MMT.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49: 1374-403.
Kassouf W, Hautmann RE, Bochner BH, et al. A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution? Eur Urol. 2010; 58: 374-83.
Skinner EC, Skinner DG, Stein JP. Orthotopic Urinary Diversion. In: Wein AJ, Kavoussi LR, Novick AC, editors. Campbell-Walsh Urology, 10th edn. Philadelphia; Elsevier Saunders; 2012. P. 2479-2496.
Hautmann RE. Urinary diversion: ileal conduit to neobladder. J Urol. 2003; 169: 834-42.
Hautmann RE, Volkmer BG, Schumacher MC, et al. Long-term results of standard procedures in urology: the ileal neobladder.World J Urol. 2006; 24: 305-14.
Perimenis P, Burkhard FC, Kessler TM, et al. Ileal orthotopic bladder substitute combined with an afferent tubular segment:long-term upper urinary tract changes and voiding pattern. Eur Urol. 2004; 46: 604-9.
Nyman U, Grubb A, Sterner G, et al. The CKD-EPI and MDRD equations to estimate GFR: validation in the Swedish Lund-Malmo Study cohort. Scand J Clin Lab Invest. 2011; 71: 129-38.
Eisenberg MS, Thompson RH, Frank I, et al. Long-Term Renal Function Outcomes after Radical Cystectomy. J Urol. 2014; 91: 619-25.
Jin XD, Roethlisberger S, Burkhard FC, et al. Long-term Renal Function After Urinary Diversion by Ileal Conduit or Orthotopic Ileal Bladder Substitution. Eur Urol. 2012; 61: 491-7.
Nishikawa M, Miyake H, Yamashita M, et al. Long-term changes in renal function outcomes following radical cystectomy and urinary diversion. Int J Clin Oncol. 2014; 19: 1105-11.
Makino K, Nakagawa T, Kanatani A, et al. Biphasic decline in renal function after radical cystectomy with urinary diversion. Int J Clin Oncol. 2017; 22: 359-65.
Zietman AL, Sacco D, Skowronski U, et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol. 2003; 170: 1772-6.
Rödel C, Grabenbauer GG, Kuhn R, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol. 2002; 20: 3061-71.